Merck & Co. (MRK)

NYSE 137 marketed · 63 in Phase 3

Quick facts

TickerMRK (NYSE)

Marketed products

Phase 3 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Merck & Co.

What is the ticker symbol for Merck & Co.?

Merck & Co. trades as MRK on the NYSE.

What are Merck & Co.'s marketed drugs?

Top marketed products include Keytruda, Winrevair, Prevymis, Elspar, Welireg, Bavencio.

What is Merck & Co.'s pipeline?

Merck & Co. has 63 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Acetaminophen (or equivalent), Amoxicillin/clavulunate potassium, Background PAH Therapy, Boceprevir (BOC).

How many employees does Merck & Co. have?

Merck & Co. has approximately 73,000 employees.

Related